
UCLA Broad Stem Cell Research Center/Stem Cell Reports
Human embryonic stem cell-derived neurons (green) showing nuclei in blue. Left: with retinoic acid added. Right: with retinoic acid and BMP4 added, creating proprioceptive sensory interneurons (pink).
Researchers are the first to create sensory interneurons from stem cells
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have, for the first time, coaxed human stem cells to become sensory interneurons — the cells that give us our sense of touch. The new protocol could be a step toward stem cell–based therapies to restore sensation in paralyzed people who have lost feeling in parts of their body.
The study, which was led by Samantha Butler, a UCLA associate professor of neurobiology and member of the Broad Stem Cell Research Center, was published today in the journal Stem Cell Reports.
Sensory interneurons, a class of neurons in the spinal cord, are responsible for relaying information from throughout the body to the central nervous system, which enables the sense of touch. The lack of a sense of touch greatly affects people who are paralyzed. For example, they often cannot feel the touch of another person, and the inability to feel pain leaves them susceptible to burns from inadvertent contact with a hot surface.
“The field has for a long time focused on making people walk again,” said Butler, the study’s senior author. “‘Making people feel again doesn’t have quite the same ring. But to walk, you need to be able to feel and to sense your body in space; the two processes really go hand in glove.”
In a separate study, published in September by the journal eLife, Butler and her colleagues discovered how signals from a family of proteins called bone morphogenetic proteins, or BMPs, influence the development of sensory interneurons in chicken embryos. The Stem Cell Reports research applies those findings to human stem cells in the lab.
When the researchers added a specific bone morphogenetic protein called BMP4, as well as another signaling molecule called retinoic acid, to human embryonic stem cells, they got a mixture of two types of sensory interneurons. DI1 sensory interneurons give people proprioception — a sense of where their body is in space — and dI3 sensory interneurons enable them to feel a sense of pressure.
The researchers found the identical mixture of sensory interneurons developed when they added the same signaling molecules to induced pluripotent stem cells, which are produced by reprogramming a patient’s own mature cells such as skin cells. This reprogramming method creates stem cells that can create any cell type while also maintaining the genetic code of the person they originated from. The ability to create sensory interneurons with a patient’s own reprogrammed cells holds significant potential for the creation of a cell-based treatment that restores the sense of touch without immune suppression.
Butler hopes to be able to create one type of interneuron at a time, which would make it easier to define the separate roles of each cell type and allow scientists to start the process of using these cells in clinical applications for people who are paralyzed. However, her research group has not yet identified how to make stem cells yield entirely dI1 or entirely dI3 cells — perhaps because another signaling pathway is involved, she said.
The researchers also have yet to determine the specific recipe of growth factors that would coax stem cells to create other types of sensory interneurons.
The group is currently implanting the new dI1 and dI3 sensory interneurons into the spinal cords of mice to understand whether the cells integrate into the nervous system and become fully functional. This is a critical step toward defining the clinical potential of the cells.
“This is a long path,” Butler said. “We haven’t solved how to restore touch but we’ve made a major first step by working out some of these protocols to create sensory interneurons.”
Learn more: UCLA scientists make cells that enable the sense of touch
The Latest on: Stem cell–based therapies
[google_news title=”” keyword=”stem cell–based therapies” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stem cell–based therapies
- Canine Stem Cell Therapy Market Outlook and Forecast till 2031on March 29, 2023 at 11:13 pm
The "Canine Stem Cell Therapy Market" Study Describes how the technology industry is evolving and how major and ...
- Stem cell therapy provides high success rate in paralyzed animals: Turkish veton March 29, 2023 at 5:00 pm
Stem cell therapy offers success rates of up to 90-100% in various diseases, while the rate stands at 60-70% in paralyzed animals, Turkish veterinary surgeon Dr. Cem Perk told Anadolu on Wednesday.
- Global Market for Stem Cells 2023: Potential as Disease Treatment Options Fuels Market Momentumon March 28, 2023 at 2:15 pm
This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the ...
- Stem cell therapy: a potential cure for hearing loss?on March 28, 2023 at 7:43 am
As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market by 2023 Top Growing Regions and Competitors Analysis with Experts Studyon March 28, 2023 at 5:42 am
Mar 28, 2023 (Alliance News via COMTEX) -- Global Autologous Stem Cell and Non-Stem Cell Based Therapies Market Size study, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), By Product ...
- What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?on March 22, 2023 at 11:23 am
Autologous cell based therapies are personalized therapies ... cells are created from a patient’s own cells. Autologous stem-cell therapy is a novel medical technology that is revolutionizing ...
- What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?on March 22, 2023 at 7:13 am
Autologous cell based therapies are personalized therapies using your ... CAR-T cells are created from a patient’s own cells. Autologous stem-cell therapy is a novel medical technology ...
- Treatment of genetic disorders: Here's how stem cells can treat genetic diseaseson March 21, 2023 at 12:31 am
Health expert spills the beans on the role of cellular based therapy when it comes to genetic disorders and how stem cells can be used to treat genetic diseases ...
- Cell-based Therapies for Parkinson's Diseaseon March 9, 2023 at 4:00 pm
Nevertheless, owing to the relatively circumscribed nature of the nigrostriatal lesion in PD, dopaminergic cell transplantation has emerged as a potentially reparative therapy for the disease.
- This stem cell startup is designing a therapy to restore and boost immunityon March 1, 2023 at 7:17 am
He’d learned that other scientists had coaxed stem ... a treatment for babies born without a thymus — an extremely rare and fatal condition. If that worked, a shot of thymus cells might ...
via Bing News